Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YEFE: Fractional Doses of Yellow Fever Vaccines
NCT02991495Phase 4Completed
- Sponsor
- Illumina
- Start
- Nov 2017
- Primary completion
- Feb 2018
- Modality
- Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 4 trial of 17D yellow fever vaccine in yellow fever, sponsored by Illumina. Started Nov 2017; status: completed.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT02991495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02991495.